Delivery Order SPE2DB20D3101-SPE2DB25FRLF5
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,104.12 by the Defense Logistics Agency (DLA) on June 26, 2025, for the supply of Kerendia 20 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is scheduled for ultimate completion on June 27, 2025, with performance taking place at...
- The Defense Logistics Agency awarded a delivery order valued at $5,954.02 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $3,485.49 contract is for the supply of KERENDIA 10 MG TABLET 90S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded to AmerisourceBergen Drug Corp, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Kerendia 20 mg tablets (30-count units) with a ceiling value of $27,471.06. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on June 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's competitive...
- AmerisourceBergen Drug Corp received a $1,221.90 firm fixed price delivery order from the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Kerendia 20 mg tablets in a 30-count package. This is a non-set-aside award issued under competitive procurement. The contract is classified as a child order, indicating it derives from a larger indefinite delivery contract vehicle. Performance will be completed by September 18, 2025, with fulfillment occurring at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $19,097.35 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units) on September 17, 2025, with completion expected by September 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count supply) under a firm fixed-price contract valued at $1,492.08, with an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside delivery order was executed on September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,297.48 firm-fixed-price contract is for the delivery of KERENDIA 10 MG TABLET 30S, a pharmaceutical product. The contract has a performance period extending through May 28, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,219.50, is for the delivery of Kerendia 10 mg tablets. The contract has a period of performance through May 23, 2025 and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KERENDIA 10 MG TABLET 30S. The contract has a ceiling value of $5,107.73 and a period of performance through June 6, 2025. AmerisourceBergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania that is a critical supplier of medical and pharmaceutical products to federal agencies, including...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRLF5Delivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $16,082.62 on May 27, 2025, for the supply of Kerendia 20 mg tablets (30-count packages). This firm fixed-price delivery order, with an ultimate completion date of May 28, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard, through this comprehensive global pharmaceutical support vehicle. The company supplies a diverse portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.1k | 5/27/25 |